Legend Biotech (LEGN) Other Non-Current Assets (2020 - 2026)

Legend Biotech (LEGN) has 7 years of Other Non-Current Assets data on file, last reported at $26.5 million in Q1 2026.

• Quarterly Other Non-Current Assets rose 374.66% year-over-year to $26.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.5 million (up 374.66% YoY) and the FY2025 annual result came in at $12.4 million, down 4.62% from the prior year.
• Other Non-Current Assets climbed to $26.5 million in Q1 2026, from $12.4 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $26.5 million in Q1 2026 to a low of $1.1 million in Q1 2023.
• A 5-year average of $7.4 million and a median of $1.9 million in 2024 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets surged 618102.36% — and 2023, when it sank 95.69%.
• Tracing LEGN's Other Non-Current Assets over 5 years: stood at $1.5 million in 2022, then rose by 0.4% to $1.5 million in 2023, then soared by 770.73% to $13.0 million in 2024, then retreated by 4.62% to $12.4 million in 2025, then soared by 113.71% to $26.5 million in 2026.
• The last three Other Non-Current Assets figures came in at $26.5 million (Q1 2026), $12.4 million (Q4 2025), and $11.0 million (Q3 2025), per Business Quant data.